Evidence map›Paper›PMID 29470111›Full record

ArticleAmerican journal of public health2018

Long-Acting Reversible Contraception Free of Charge, Method Initiation, and Abortion Rates in Finland.

Frida Gyllenberg, Mikael Juselius, Mika Gissler, Oskari Heikinheimo

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Frida GyllenbergFrida Gyllenberg and Oskari Heikinheimo are with the Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland. Frida Gyllenberg is also with the City of Vantaa, Vantaa, Finland. Mikael Juselius is with the Bank of Finland, Helsinki. Mika Gissler is with the Information Services Department, National Institute for Health and Welfare, Helsinki, and with Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Stockholm, Sweden.
Mikael JuseliusFrida Gyllenberg and Oskari Heikinheimo are with the Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland. Frida Gyllenberg is also with the City of Vantaa, Vantaa, Finland. Mikael Juselius is with the Bank of Finland, Helsinki. Mika Gissler is with the Information Services Department, National Institute for Health and Welfare, Helsinki, and with Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Stockholm, Sweden.
Mika GisslerFrida Gyllenberg and Oskari Heikinheimo are with the Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland. Frida Gyllenberg is also with the City of Vantaa, Vantaa, Finland. Mikael Juselius is with the Bank of Finland, Helsinki. Mika Gissler is with the Information Services Department, National Institute for Health and Welfare, Helsinki, and with Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Stockholm, Sweden.
Oskari HeikinheimoFrida Gyllenberg and Oskari Heikinheimo are with the Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland. Frida Gyllenberg is also with the City of Vantaa, Vantaa, Finland. Mikael Juselius is with the Bank of Finland, Helsinki. Mika Gissler is with the Information Services Department, National Institute for Health and Welfare, Helsinki, and with Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Stockholm, Sweden.
National Bureau of Investigation · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate whether a public program providing long-acting reversible contraceptive (LARC) methods free of charge increases the LARC initiation rate and reduces the unintended pregnancy rate in the general population.

methodsSince 2013, all women in Vantaa, Finland, have been entitled to 1 LARC method free of charge. With time-series analysis between 2000 and 2015, we assessed whether this public program was associated with changes in steady-state mean rates of LARC initiation and abortions.

resultsThe initiation rate of LARCs (1/1000 women) increased 2.2-fold from 1.9 to 4.2 after the intervention (P < .001). Concomitantly, the abortion rate (1/1000 women) declined by 16% from 1.1 to 0.9 in the total sample (P < .001), by 36% from 1.3 to 0.8 among those aged 15 to 19 years (P < .001), and by 14% from 2.0 to 1.7 among those aged 20 to 24 years (P = .01).

conclusionsThe LARC program was associated with increased uptake of LARC methods and fewer abortions in the population. Public Health Implications. Entitling the population to LARC methods free of charge is an effective means to reduce the unmet need of contraception and the need for abortion, especially among women younger than 25 years.

Indexed as

Abortion, InducedAdolescentAdultFees, MedicalFemaleFinlandHumansLong-Acting Reversible ContraceptionYoung Adult

Identifiers

PMID29470111
PMCPMC5844404
OpenAlexW2788716815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.